China SXT Pharmaceuticals, Inc. (SXTC )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol SXTC
- Company China SXT Pharmaceuticals, Inc.
- Price $3
- Changes Percentage 6.38
- Change 0.18
- Day Low $2.63
- Day High $3.15
- Year High $1047
- Year Low $2.63
- Market Cap $2,560,542
- Price Avg 50 EMA (D) $139.82
- Price Avg 200 EMA (D) $218.73
- Exchange NASDAQ
- Volume 138,360
- Average Volume 184,626
- Open $2.81
- Previous Close $2.82
- EPS -57.15
- PE -0.05
- Earnings Announcement 2023-07-17 04:00:00
- Shares Outstanding $853,514
Company brief: CHINA SXT PHARMACEUTICALS, INC. (SXTC )
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Mr. Feng Zhou
- https://www.sxtchina.com
- CN
- N/A
- 01-04-2019
- VGG2161P1403
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.